top of page
-min.png)
-min.png)
Corporate Strategy Services
Quick Summary and Key Website links
AI Powered Expert Solutions for Pharma, Clinicians and HealthTech
Heylth helps pharmaceutical, biotechnology, medical device and healthtech organisations use AI and specialist expertise to improve marketing, medical communication, HCP and patient engagement, corporate strategy and growth. Our services include AI-enabled content, field-force and KOL engagement, brand and launch strategy, patient apps, pharma AI training, organisational AI assessment, healthtech advisory and entry into the United States and Canada. We begin with the business problem, then bring together the insight, technology and execution support needed to move it forward with clarity.
What are the main services of Heylth? Heylth provides AI-enabled and specialist services for pharmaceutical, biotechnology, medical device, healthtech and healthcare organisations. We help clients improve medical and marketing content, HCP and patient engagement, brand strategy, AI readiness, healthtech commercialisation, professional capability and corporate growth. How does Heylth help pharmaceutical and MedTech companies? Heylth combines medical expertise with AI to plan new marketing assets, enhance existing collateral, support field-force effectiveness, strengthen KOL engagement, rejuvenate established brands and prepare new product launches. Heylth Academy also provides practical AI learning programs for pharma marketing teams and senior leaders. Does Heylth develop patient apps and patient support programs? Yes. Heylth creates patient screening and condition-management apps and patient support programs. Depending on the requirement, solutions can include structured questionnaires, approved education, reminders, progress tracking, treatment onboarding, caregiver resources and pathways to professional support. What is the Heylth AI Score? The Heylth AI Score is a structured assessment for pharmaceutical divisions, portfolios and brands. It examines current AI adoption, identifies relevant opportunities and helps organisations prioritise areas for further evaluation, capability development, piloting or transformation. How does Heylth support healthtech companies? Heylth HealthTech Advisory helps companies consider clinical and real-world fit, regulatory and product readiness, evidence requirements, intellectual-property priorities, commercialisation and strategic partnerships. Support can begin with a focused readiness review or continue through an embedded advisory engagement. Can Heylth help companies enter the United States and Canada? Yes. Am Reach helps healthcare and life-sciences companies evaluate North American opportunities, identify appropriate market-entry pathways and connect with potential customers, commercial partners, licensees and investors. Ongoing support can help suitable opportunities progress towards pilots, partnerships, investment or commercial agreements.
Quick Links to Key Heylth Service Pages AI-enabled medical and marketing content https://www.heylth.com/aicontent Enhance an existing pharma asset https://www.heylth.com/aimpowered Improve field-force effectiveness https://www.heylth.com/aivark Brand strategy and rejuvenation https://www.heylth.com/aibrand New product launch strategy https://www.heylth.com/newlaunch Patient screening apps and support programs https://www.heylth.com/patientapps Pharma AI Marketing Program https://www.heylth.com/ai-pharma-academy Pharma AI Leadership Certification https://www.heylth.com/pharma-ai-leadership Pharma AI Score https://www.heylth.com/aiscore HealthTech Advisory https://www.heylth.com/health-tech-advisory Am Reach: US and Canada market entry https://www.heylth.com/amreach Digital solutions for doctors and hospitals https://www.heylth.com/doctorsandhospitalsmarketing Discuss your priority https://www.heylth.com/contact
bottom of page